Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 38

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 38
---
     | $              | 60.00 |     | July               
 16, 2034           |     |                                                      | - |     | $                                                          | - |
| Kristen                                                                 
 Landon,                                                                 
 Chief Commercial Officer(3)                                             |     |                                                               |   834 |     |                                                                | - |     |                                                                                     | 3,333 |     | $              |  6.85 |     | September 26, 2034 |     |                                                      | - |     | $                                                          | - |

| (1) | Dr. Dow’s options to                                                                                                                 
 purchase a total of 5,000 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with 
 the first vesting date being December 31, 2024.                                                                                      |

| (2) | Mr. Miller’s options                                                                                                                    
 to purchase a total of 4,000 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with 
 the first vesting date being December 31, 2024.                                                                                         |

| (3) | Ms. Landon’s options                                                                                                                    
 to purchase a total of 4,167 shares of our common stock vest annually on the last date of each fiscal year in five equal tranches, with 
 the first vesting date being December 31, 2024.                                                                                         |

<div align='center'>DELINQUENT SECTION 16(a) REPORTS</div>

Section 16(a) of the Securities Exchange Act of
1934, as amended, requires our directors, executive officers and persons who own more than 10% of the outstanding shares of common stock
of the Company to file with the SEC reports of their ownership and changes in their ownership of common stock of the Company. Directors,
executive officers and greater-than-ten percent shareholders are also required to furnish the Company with copies of all ownership reports
they file with the SEC. To our knowledge, based solely on a review of the copies of such reports furnished to the Company, Cheryl Xu failed
to file a timely Form 4 with regard to the purchase of common shares on 27 August, 2024, December 12, 2024, and December 13, 2024, and
Kristen Landon failed to file a Form 4 with respect to Options issued on September 26, 2024 and January 17, 2025